MENU
THTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Theratechnologies (THTX) Ownership - Who owns Theratechnologies?
Profile
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
75.26M
P/E Ratio
N/A
Total Cash
38.86M
Projected Growth
N/A
Total Debt
57.83M
Revenue
84.32M
Risk (Beta)
0.66
Dividend Yield
N/A
Total Cash/Share
0.85
Total Debt/Equity
N/A
Revenue/Share
1.86 USD as % of share price
Fundamentals
THTX
Capitalization
75.3M
P/E Ratio
N/A
Risk (Beta)
0.66
Dividend Yield
N/A
Total Cash
38.9M
Total Cash/Share
0.85
Total Debt
57.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.86%
Revenue
84.3M
ROE
N/A
Book Value
-19.68M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
364M
Current Ratio
1.08
Current Revenue Per Employee
219417.47
Dividends Per Share - Security
N/A
EBITDA
11.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.00
Revenue To Assets
-5.00
Shares Held By Institutions
26.3M
Shares Outstanding - Current
46M
Total Liabilities
89.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
0.000
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV)
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com